Resurfacing Acne Swipes

Description

No description information is available for the specified drug.

Uses and Indications

This drug is indicated for the treatment of acne. It effectively reduces the number of acne pimples and blackheads, facilitates skin healing, and helps prevent the formation of new acne pimples.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

Healthcare professionals should ensure that the skin is thoroughly cleansed prior to the application of the product. The product is to be applied using the provided pad, which should be used to clean and treat the entire affected area. Applications may be performed one to three times daily, based on the severity of the condition and the patient's response.

It is important to note that the product should not be rinsed off after application. To minimize the risk of excessive drying of the skin, it is recommended to initiate treatment with one application per day. The frequency of application may be gradually increased as needed or as directed by a healthcare provider.

In cases where bothersome dryness or peeling occurs, the frequency of application should be reduced to alleviate these symptoms.

Contraindications

There are no specific contraindications listed for this product. However, it is advised that if the product is swallowed, immediate medical assistance should be sought or the Poison Control Center should be contacted.

Warnings and Precautions

For external use only. This product is contraindicated in individuals with very sensitive skin or a known allergy to aspirin. Healthcare professionals should advise patients to discontinue use and seek medical attention if they experience excessive itching, dryness, redness, burning, or swelling, or if these symptoms persist.

When utilizing this product, it is imperative to avoid contact with the eyes, lips, and other mucous membranes. In the event of contact, the affected area should be flushed thoroughly with water. Additionally, patients should be cautioned against leaving the pad on the skin for an extended duration. The concurrent use of other topical acne medications may exacerbate skin dryness or irritation; therefore, it is recommended that only one medication be used at a time unless otherwise directed by a healthcare provider.

Sunburn Alert: This product contains an alpha hydroxy acid (AHA), which may heighten the skin's sensitivity to sunlight and increase the risk of sunburn. Patients should be advised to apply sunscreen, wear protective clothing, and limit sun exposure while using this product and for one week following its discontinuation.

In the case of accidental ingestion, immediate medical assistance should be sought, or the Poison Control Center should be contacted without delay.

Side Effects

Patients using this product may experience a range of adverse reactions, which can be categorized based on their seriousness and frequency.

Serious adverse reactions include excessive itching, dryness, redness, burning, or swelling. Patients are advised to discontinue use and consult a healthcare professional if any of these symptoms occur or persist. Additionally, the product is contraindicated for individuals with very sensitive skin or known allergies to aspirin.

Common adverse reactions associated with the use of this product may include increased skin sensitivity, particularly due to the presence of alpha hydroxy acid (AHA). This ingredient can heighten the risk of sunburn; therefore, patients are cautioned to use sunscreen, wear protective clothing, and limit sun exposure while using the product and for one week following its use.

When using this product, it is important for patients to avoid contact with eyes, lips, and other mucous membranes. In the event of contact, thorough flushing with water is recommended. Furthermore, patients should not leave the pad on the skin for an extended period. The concurrent use of other topical acne medications may exacerbate dryness or irritation; thus, it is advised that only one medication be used at a time unless directed otherwise by a healthcare provider.

Drug Interactions

There are currently no documented drug interactions associated with this medication. Additionally, there is no information available regarding interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are warranted at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Resurfacing Acne Swipes (salicylic acid). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be advised to keep the medication out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or the Poison Control Center should be contacted.

For topical application, it is recommended to initiate treatment with one application daily to minimize the risk of excessive skin drying. Dosage may be gradually increased as needed or directed by a healthcare professional. If patients experience bothersome dryness or peeling, they should reduce the frequency of application.

Geriatric Use

Elderly patients may not have specific information regarding the use of this medication, including dosage adjustments, safety concerns, or special precautions. Therefore, healthcare providers should exercise caution when prescribing this medication to geriatric patients. It is advisable to monitor these patients closely for any adverse effects or changes in therapeutic response, given the lack of targeted data for this population.

Pregnancy

The product has not been evaluated for use during pregnancy. There are no specific warnings or contraindications associated with the use of this product in pregnant patients. Additionally, no dosage modifications are recommended for individuals who are pregnant. Furthermore, the prescribing information does not indicate any special precautions regarding pregnancy. Healthcare professionals should consider the lack of data when prescribing this product to women of childbearing potential and weigh the potential benefits against any unknown risks.

Lactation

There are no specific statements regarding the use of this medication in nursing mothers or lactation. Therefore, the effects on breastfed infants and the excretion of the drug in human milk are not established. Healthcare professionals should consider the lack of data when advising lactating mothers about the use of this medication.

Renal Impairment

There is no information available regarding renal impairment, dosage adjustments, special monitoring, or safety considerations for patients with reduced kidney function. Healthcare professionals should exercise clinical judgment when prescribing to patients with renal impairment, as specific recommendations are not provided in the available data.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the absence of specific overdosage information, it is essential for healthcare professionals to remain vigilant regarding the potential for overdose with this medication. In cases where an overdose is suspected, immediate medical attention should be sought.

Healthcare providers are advised to monitor patients closely for any signs or symptoms that may indicate an overdose. These may include, but are not limited to, increased severity of known side effects, altered mental status, or any unusual physiological responses.

Management of an overdose should be guided by the clinical presentation of the patient. Supportive care is paramount, and symptomatic treatment should be initiated as necessary. It is recommended that healthcare professionals consult local poison control centers or relevant clinical guidelines for specific management protocols tailored to the substance involved.

In summary, while no specific overdosage information is available, healthcare professionals should exercise caution, remain alert to potential overdose symptoms, and implement appropriate management strategies in the event of an overdose scenario.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the compound in these areas.

Postmarketing Experience

Postmarketing experience has identified the following adverse reactions reported voluntarily or through surveillance programs: skin irritation, allergic reactions, and contact dermatitis. These events have been documented in the context of routine pharmacovigilance activities.

Patient Counseling

Healthcare providers should advise patients that in the event of accidental ingestion, it is crucial to seek medical assistance immediately or contact the Poison Control Center. This prompt action is essential to ensure patient safety and appropriate management of any potential risks associated with swallowing the medication.

Storage and Handling

The product is supplied in a jar that must be kept tightly closed to maintain its integrity. It should be stored at room temperature to ensure optimal quality and effectiveness.

Additional Clinical Information

The product is administered topically, with the recommended application being one to three times daily to clean and treat the entire affected area. Clinicians should counsel patients regarding the potential for increased skin sensitivity due to the presence of alpha hydroxy acid (AHA) in the formulation. Patients are advised to use sunscreen, wear protective clothing, and limit sun exposure while using the product and for one week thereafter to mitigate the risk of sunburn. Daily application of SPF is also recommended during the treatment period.

Drug Information (PDF)

This file contains official product information for Resurfacing Acne Swipes, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)